OraSure Technologies Inc. 220 East First Street Bethlehem,
PA 18015-1360 United States - Map Phone: 610-882-1820 Fax: 610-882-1830 Website: http://www.orasure.com
OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States and internationally. Its products include OraQuick ADVANCE HIV-1/2, a point-of-care qualitative test for antibodies to the Human Immunodeficiency Virus (HIV) Type 1 and 2; OraQuick HCV, a point-of-care qualitative test for antibodies to the hepatitis C virus; OraSure QuickFlu Rapid Flu A&B Test, a point-of-care qualitative test for antibodies to influenza Types A and B, including H1N1 infections; OraSure, an oral fluid collection device for the detection of antibodies to HIV-1 in an oral fluid sample; and Intercept, an oral fluid collection device for oral fluid drugs of abuse testing in a laboratory setting. The companys products also comprise cryosurgical systems for the removal of common and plantar warts, and other benign skin lesions; Oragene DX, OMNIgene DISCOVER, ORAcollect, and OrageneDNA, which are non-invasive systems for the collection, stabilization, transportation, and storage of human DNA from saliva; OMNIgeneDISCOVER, a non-invasive all-in-one system for the collection, stabilization, transportation, and storage of microbial DNA from saliva; and Performagene LIVESTOCK and Oragene ANIMAL systems for the collection, stabilization, transportation, and storage of livestock DNA from nasal samples. In addition, it sells immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test; and Q.E.D. rapid point-of-care saliva alcohol test. The company sells its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians offices, and commercial and industrial entities. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania. Key Statistics
| |
| OraSure Technologies Inc.’s Governance Risk Indicator (GRI®) as of May 1, 2012 is: Audit (Low Concern), Board (Low Concern), Compensation (Medium Concern), Shareholder Rights (High Concern). | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Mr. Douglas A. Michels ,
55 Chief Exec. Officer, Pres and Director | 889.00K | 0.00 | Mr. Ronald H. Spair ,
56 Chief Operating Officer, Chief Financial Officer, Head of Investor and Director | 625.00K | 207.00K | Mr. Jack E. Jerrett ,
53 Sr. VP, Sec. and Gen. Counsel | 430.00K | 63.00K | Dr. Stephen R. Lee Ph.D.,
52 Chief Science Officer and Exec. VP | 478.00K | 86.00K | Mr. Anthony Zezzo II,
Exec. VP of Marketing and Sales | 479.00K | 0.00 |
|
| | Amounts are as of Dec 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|